Strides Pharma Science gets USFDA nod for generic capsule to control triglyceride level

The product is bioequivalent and therapeutically equivalent to the reference listed drug Vascepa of Amarin. It will be manufactured at the company's facility in Bengaluru, it added. The Icosapent Ethyl capsules have a market size of around USD 1.3 billion, Strides said, citing IQVIA.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qJQdVBc
via IFTTT